Can peripheral leukocytes be used as Alzheimer's disease biomarkers? - Wikidata - wikimedia - TriplyDB

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

http://www.wikidata.org/entity/Q33689076

about

Traumatic Brain Injury Induces Genome-Wide Transcriptomic, Methylomic, and Network Perturbations in Brain and Blood Predicting Neurological Disorders.Leukocyte CCR2 expression is associated with mini-mental state examination score in older adults.Defective mitochondrial respiration, altered dNTP pools and reduced AP endonuclease 1 activity in peripheral blood mononuclear cells of Alzheimer's disease patients.Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.Impact of the CD40-CD40L dyad in Alzheimer's disease Macrophages in Alzheimer's disease: the blood-borne identity.Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer's disease pathogenesis.Immunotherapies in Alzheimer's disease: Too much, too little, too late or off-target?Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer's Disease Patients. Relevant Role of Neutrophils in Oxidative Stress.Exploring Erythrocytes as Blood Biomarkers for Alzheimer's Disease.

P2860

Q33809775-869C3106-E1D3-4D87-8A88-593B2C21DD1A Q34275897-73CBDA34-D07E-4143-A19F-F91F9260275F Q36260240-52E3FA56-0004-4430-B2B7-5C35174A5A45 Q37129119-13B0025C-B6C1-47E0-A1E5-1FB131253BFE Q37703298-22AEFD6A-D115-4C1A-8AC5-077AB8EEF1B4 Q37762195-03475A2A-9551-4517-BA44-DED036DC0538 Q38657053-E52F1C6A-17FD-44FE-ADC4-E3F2048B2CE2 Q38675216-73316566-8D98-4777-A059-86068A980DA1 Q47551263-B3427CFA-069D-4333-AD54-F1312F861E4B Q47687712-36F0ACE5-6578-493D-9A26-097B3E28A059

P2860

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

http://www.wikidata.org/entity/Q33689076

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

@ast

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

@en

type

label

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

@ast

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

@en

prefLabel

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

@ast

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

@en

P1433

Q33689076-D7F27450-EFFE-4BE7-8752-C0D06278CDB2

P1476

Q33689076-8CB9C6B2-4E66-489B-9F01-1143E7CDD418

P2093

Q33689076-49E50B51-EE47-437F-9940-AE369D5ACCDE

Q33689076-A75C24E3-60EA-4A11-A34B-F997CF20005E

Q33689076-F8DA63A4-425E-44D3-A797-5B8CC645BB4F

P2860

Q33689076-013626BE-17B7-4A8B-BDBB-2802562B5717

Q33689076-02DABFBD-609F-4606-A5B9-DC0C8D2FE005

Q33689076-0BDA0785-1317-436D-9AF9-37C8ED3EDF10

Q33689076-0C2EC36C-702A-4C6C-AEDB-571095FAF7FB

Q33689076-0CA3A46F-3489-4C98-A35F-648954EC1AE4

Q33689076-0E75F76C-F500-4CCD-B225-28A5DE1870F1

Q33689076-107F879A-4D9F-48F7-B977-D93AEDE0BFB9

Q33689076-10D55548-4B81-47F3-B556-6822D654A771

Q33689076-11EFB8D6-A5D4-4207-9194-C68BBA5A8B3E

Q33689076-12C0EC05-4EB8-4E46-AEEC-B29E24A2AA3E

P304

Q33689076-44408A22-3B72-441D-87D8-53B06B426F31

P31

Q33689076-320E5EA2-B3EF-4356-9E65-98EC60B876FB

P356

Q33689076-29009649-295A-4C9B-B476-0B9A7E98F437

P433

Q33689076-EB0D944D-FA57-42C9-9849-61FAD955BA4B

P478

Q33689076-B5906710-6591-4C15-A057-BAE95134494C

P50

Q33689076-70BE9724-4530-4820-AA39-D34D3FC8C6B7

P577

Q33689076-E54DFE80-636F-40A4-AB52-96DE7ED13A83

P5875

Q33689076-FC4EC978-A076-4495-A71C-459290D0B56F

P698

Q33689076-06615971-4BCF-46F0-ABE2-25828F9DD46F

P921

Q33689076-0A90A3C8-B467-4561-B7E7-D1C22F528BDB

Q33689076-8912583A-EF96-4303-A097-305B53AB5CD3

P932

Q33689076-8AED62FE-B5FE-4E08-9F3B-0A50717083C5

P356

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

@en

P2093

Christine A Szekely

http://www.w3.org/2001/XMLSchema#string

Kavon Rezai-Zadeh

http://www.w3.org/2001/XMLSchema#string

Terrence Town

http://www.w3.org/2001/XMLSchema#string

P2860

NSAIDs for the Chemoprevention of Alzheimer’s Disease

Alzheimer Disease in the US Population

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin

The microglial "activation" continuum: from innate to adaptive responses

Aging: a theory based on free radical and radiation chemistry

Alzheimer's disease: genes, proteins, and therapy

Inflammation and Alzheimer's disease

CD40-CD40 ligand

Review: history of the amyloid fibril

P304

1623-1633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERN.09.118

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38079771

http://www.w3.org/2001/XMLSchema#string

P698

19903022

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2828773

http://www.w3.org/2001/XMLSchema#string